Frontlight ResearchEarly access
Amyloidosis trials in United Kingdom
7 of 20 trials · From ClinicalTrials.gov, checked 16 November 2026. Ask the study team whether a trial fits you.
- No phaseTaking peopleLong-term Safety of Eplontersen Treated aTTR Patients and in Liver Transplant and Severely Hepatic Impaired Subpopulations
- Where
- Birmingham
- Age
- 18 years and over
- People
- 320 worldwide
- Run by
- AstraZeneca
See details and how to joinNCT07654855 - No phaseTaking peopleMulticenter Study for the Validation of an AI-based ECG Platform for Early Cardiac Amyloidosis Diagnosis
- Where
- Glasgow
- Age
- 18 years and over
- People
- 2,200 worldwide
- Run by
- Idoven 1903 S.L.
See details and how to joinNCT06978660 - No phaseTaking peopleA Study to Learn About the Use of Acoramidis in Patients With a Heart Condition Called Transthyretin Amyloid Cardiomyopathy (ATTR-CM) in a Real-world Setting
- Where
- Multiple Locations
- Age
- 18 years and over
- People
- 2,000 worldwide
- Run by
- Bayer
See details and how to joinNCT07235462 - No phaseTaking peopleNon-interventional Study of Patients With Transthyretin (ATTR) Amyloidosis
- Where
- Birmingham, Glasgow, London
- Age
- 18 years to 130 years
- People
- 1,850 worldwide
- Run by
- AstraZeneca
See details and how to joinNCT06465810 - No phaseCompletedOverTTuRe: Characteristics, Treatment Patterns and Outcomes of Patients With ATTR Amyloidosis
- Where
- London
- People
- 52,121 worldwide
- Run by
- AstraZeneca
See details and how to joinNCT06355934 - Phase 2/3Enrolling by invitationLong-Term Follow-Up (LTFU) of Subjects Dosed With NTLA-2001
- Where
- London
- Age
- 18 years and over
- People
- 72 worldwide
- Run by
- Intellia Therapeutics
See details and how to joinNCT05697861 · EU 2023-507385-11-00 - No phaseTaking peopleNational Registry of Rare Kidney Diseases
- Where
- Bristol
- People
- 35,000
- Run by
- UK Kidney Association
See details and how to joinNCT06065852